Ophthalmology Drugs and Devices Market Size Industry Leaders & New Revenue Pockets – 2027
Market Study Report Has Added A New Report On Ophthalmology Drugs And Devices Market That Provides A Comprehensive Review Of This Industry With Respect To The Driving Forces Influencing The Market Size. Comprising The Current And Future Trends Defining The Dynamics Of This Industry Vertical, This Report Also Incorporates The Regional Landscape Of Ophthalmology Drugs And Devices Market In Tandem With Its Competitive Terrain.
Market Research predicts that the global market for ophthalmology drugs and devices is set to witness a CAGR of 6.16% over the forecast period 2019-2027.
Request a sample of this premium report titled GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 at https://www.marketstudyreport.com/request-a-sample/2487432?utm_source=marketwatch.com&utm_medium=ADS
The global ophthalmology drugs and devices market is primarily driven by the rising prevalence of eye-related diseases as well as the innovation leading to the development of new ophthalmological drugs. Ophthalmic devices and drugs are used in the treatment and identification of certain ocular malformations and deficits in the eyes.
Factors like growth in the elderly populace, increasing ophthalmic disorders caused by high blood sugar, upsurge in healthcare expenditure and advancements in technology are driving the ophthalmology drugs and devices market. Whereas, drug approval delay, coupled with several drugs in the pipeline, low awareness of ophthalmic drugs and brand patent expirations have affected the pharmaceutical industry, thus restraining the market growth. Rising opportunities for ophthalmic drugs in developing countries and the demand for intraocular lenses and phacoemulsification devices provide further support to the market growth. However, risks associated with the treatment of ocular diseases are creating challenges for the growth of the ophthalmology drugs and devices market.
The Asia-Pacific, Latin America, Europe, North America and the Middle East and Africa are the regions that form the global ophthalmology drugs and devices market.
North America is the market leader for ophthalmic drugs and devices market, worldwide. The ophthalmology drugs and devices market in North America is driven primarily due to the high healthcare and R&D expenditure in the US and Canada, coupled with the high prevalence of eye diseases in the region. Such high spending on healthcare, coupled with demand for quality healthcare, asserts the adoption of novel healthcare ailments, thus, positively supplementing the ophthalmology drugs and devices market growth. Furthermore, government investment to support eye research also drives the ophthalmology drugs and devices market in the North American region.
The top companies that have been studied in the ophthalmic drugs and devices market are Ziemer Group Holding AG, Valeant Pharmaceuticals International, Inc., Sun Pharmaceuticals Industries, Ltd., Santen Pharmaceutical Co., Ltd., Roche Holding AG, Pfizer, Novartis International AG, Johnson & Johnson, Inc., GlaxoSmithKline, Essilor International S.A., Carl Zeiss AG, Bayer and Allergan, Inc.
Essilor International S.A. is a France-based company engaged in the designing, manufacturing and production of ophthalmic lenses as well as ophthalmic optical equipment. The company operates its business in North America, Latin America, Europe, Asia/Oceania and Africa. At the end of 2016, Essilor International achieved revenues of $ 8.80 billion and employed around 64,000 employees across the globe. Transitions VI lenses, Varilux, Crizal and Xperio UV are some of the companyaEUR s prime products. In May 2015, Essilor International S.A. acquired a 37% stake in GKB OphthalmicsaEUR lens with $3.6 billion. The acquisition strategy was aimed to help in growing the companyaEUR s market presence and geographical presence to capture more market share.
Request a discount on standard prices of this premium report titled GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 at https://www.marketstudyreport.com/check-for-discount/2487432?utm_source=marketwatch.com&utm_medium=ADS
TABLE OF CONTENT:
1. GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTERaEUR S FIVE FORCES ANALYSIS
2.2.1. BARGAINING POWER OF BUYERS
2.2.2. BARGAINING POWER OF SUPPLIER
2.2.3. THREATS OF NEW ENTRANTS
2.2.4. THREATS OF SUBSTITUTES
2.2.5. COMPETITIVE RIVALRY
2.3. STRATEGIC OUTLOOK
2.4. MARKET SHARE OUTLOOK
2.5. KEY INSIGHT
2.6. VALUE CHAIN OUTLOOK
2.7. KEY BUYING STANDARDS
2.8. INVESTMENT OUTLOOK
2.9. SUPPLY CHAIN OUTLOOK
2.10. REGULATORY FRAMEWORK
2.11. MARKET DRIVERS
2.11.1. ELDERLY POPULATION IS INCREASING WORLDWIDE
2.11.2. INCREASING OPHTHALMIC DISORDERS DUE TO HIGH BLOOD SUGAR
2.11.3. UPSURGE IN HEALTHCARE SPENDING
2.11.4. TECHNOLOGICAL ADVANCEMENT
2.12. MARKET RESTRAINTS
2.12.1. EXPIRATIONS OF BRAND PATENTS HAVE AFFECTED THE PHARMACEUTICAL INDUSTRY
2.12.2. LOW COGNIZANCE RELATED TO OPHTHALMIC DRUGS
2.12.3. DRUG APPROVALS DELAY AND NUMBER OF DRUGS IN THE PIPELINE
2.13. MARKET OPPORTUNITIES
2.13.1. INCREASING DEMAND FOR PHACOEMULSIFICATION DEVICES AND INTRAOCULAR LENSES
2.13.2. RISING OPPORTUNITIES IN THE DEVELOPING COUNTRIES
2.14. MARKET CHALLENGES
2.14.1. DIFFICULTIES ASSOCIATED WITH THE CONDUCT OF OCULAR DISEASES
3. OPTHALMOLOGY DRUGS AND DEVICES MARKET OUTLOOK – BY DRUGS AND DEVICES
3.1.1. DIAGNOSTIC & MONITORING EQUIPMENT
184.108.40.206. OPTICAL COHERENCE TOMOGRAPHY
220.127.116.11. OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
18.104.22.168. FUNDUS CAMERA MARKET
22.214.171.124. WAVEFRONT ABERROMETERS
126.96.36.199. PERIMETERS/VISUAL FIELD ANALYZER
188.8.131.52. SPECULAR MICROSCOPE
4. OPTHALMOLOGY DRUGS AND DEVICES MARKET – REGIONAL OUTLOOK
4.1. NORTH AMERICA
4.1.1. MARKET BY DRUGS AND DEVICES
184.108.40.206. MARKET BY DEVICES
220.127.116.11. MARKET BY DRUGS
4.1.2. COUNTRY ANALYSIS
18.104.22.168. THE UNITED STATES
4.2.1. MARKET BY DRUGS AND DEVICES
22.214.171.124. MARKET BY DEVICES
5. COMPETITIVE LANDSCAPE
5.1. ALLERGAN, INC.
5.3. CARL ZEISS AG
5.4. ESSILOR INTERNATIONAL S.A.
5.6. JOHNSON & JOHNSON, INC.
5.7. NOVARTIS INTERNATIONAL AG
5.9. ROCHE HOLDING AG
5.10. SANTEN PHARMACEUTICAL CO., LTD.
5.11. SUN PHARMACEUTICALS INDUSTRIES, LTD.
5.12. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
5.13. ZIEMER GROUP HOLDING AG
6. METHODOLOGY AND SCOPE
6.1. RESEARCH SCOPE
6.2. SOURCES OF DATA
6.3. RESEARCH METHODOLOGY
Questions? Get them answered via https://www.marketstudyreport.com/enquiry-before-buying/2487432?utm_source=marketwatch.com&utm_medium=ADS before taking a buying decision on this premium report titled GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
US Toll Free: 1-866-764-2150
The post Ophthalmology Drugs and Devices Market Size Industry Leaders & New Revenue Pockets – 2027 appeared first on America News Hour .